A prospective, multicenter study of the effect of progressive peritoneal dialysis mode on the rate of decline of residual renal function in patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050199

Enrollment

Unknown

Registered

2021-08-22

Start date

2021-09-01

Completion date

Unknown

Last updated

2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease

Interventions

Full Dialysis group:Full Dialysis

Progressive Dialysis Group:Progressive Dialysis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. eGFR from 3 to 8ml/min; 2. Need long-term renal replacement therapy; 3. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. The primary disease is an immune disease (such as systemic lupus erythematosus, vasculitis, kidney damage, etc.); 2. Tumor; 3. Obstructive nephropathy; 4. Acute Kidney Injury; 5. Unwilling to choose peritoneal dialysis treatment.

Design outcomes

Primary

Measure	Time frame
Dialysis adequacy;Hemoglobin;albumin;blood pressure;Urine volume;	—

Countries

China

Contacts

Public ContactLv Jing

The First Affiliated Hospital of Xi'an Jiaotong University

drlvjing@163.com+86 13096938232

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026